Table 2.
Weeks after admission
|
|||||
---|---|---|---|---|---|
Overall | Week 1 | Weeks 2 – 3 | Weeks 4+ | p-value | |
| |||||
Bloodstream infection | 1.82 (1.52–2.18) | 1.27 (0.84–1.93) | 1.32 (0.92–1.90) | 2.66 (2.08–3.39) | <0.001 |
| |||||
Skin and soft tissue infection | 1.73 (1.45–2.07) | 5.86 (4.82–7.13) | 0.65 (0.39–1.10) | 0.14 (0.05–0.36) | <0.01 |
| |||||
Ventilator-associated pneumonia | 1.20 (0.96–1.50) | 0.63 (0.35–1.14) | 1.17 (0.80–1.72) | 1.59 (1.18–2.14) | 0.01 |
| |||||
Catheter-associated UTI | 1.06 (0.84–1.34) | 0.63 (0.35–1.14) | 0.72 (0.44–1.17) | 1.62 (1.21–2.18) | 0.001 |
| |||||
Tracheobronchitis | 0.90 (0.70–1.15) | 0.40 (0.19–0.85) | 0.90 (0.58–1.39) | 1.20 (0.86–1.68) | 0.01 |
| |||||
Non-device UTI | 0.43 (0.30–0.61) | 0.46 (0.23–0.92) | 0.36 (0.18–0.72) | 0.46 (0.27–0.78) | 0.83 |
| |||||
Surgical site infection | 0.41 (0.29–0.59) | 0.06 (0.00–0.41) | 0.40 (0.21–0.77) | 0.62 (0.40–0.98) | <0.0001 |
| |||||
C. difficile | 0.14 (0.08–0.26) | NA* | 0.18 (0.07–0.47) | 0.19 (0.09–0.43) | 0.06 |
| |||||
Non-ventilator associated pneumonia | 0.13 (0.07–0.24) | 0.06 (0.00–0.41) | 0.09 (0.02–0.36) | 0.19 (0.09–0.43) | 0.37 |
| |||||
Other infections† | 0.45 (0.32–0.64) | 0.17 (0.06–0.54) | 0.36 (0.18–0.72) | 0.69 (0.45–1.07) | 0.02 |
First infection per patient was included. Rates were calculated using Poisson regression and are expressed in incident cases per 1,000 patient/days. P-values were calculated using likelihood ratio tests comparing rates during various periods.
No C. difficile infections occurred during the first week after admission.
Other infections include cardiovascular infections, other respiratory infections, ear/eyes/nose/throat infections, and non-C. difficile gastrointestinal infections. UTI: urinary tract infection.